The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...
Sami Allen is the managing editor at Forbes Home, with over seven years of experience in the home space and 10 years of editing experience. Sami Allen is the managing editor at Forbes Home, with over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback